Which means that once we get confirmation of P1 tr
Post# of 72440
That in my estimation is the beginning of when some BP may jump in with both feet to get the rights to B-IBD. Not saying it will happen, but it is the time they are all playing with fire in being too late with a bid to acquire such a highly valued drug with a wide, wide scope of valuable revenue streams.
Should have data results in Feb per PRs, the sooner the better.